INS and metabolic dysfunction-associated steatotic liver disease: A similar trend of gene expression changes was observed in the genes associated with the endocrine system (insulin signaling and glucagon signaling pathways), lipid metabolism (primary and secondary bile acid biosynthesis), endocrine and metabolic diseases, and nonalcoholic fatty liver disease (NAFLD).